Roche Holding (SWX:ROP) Ebola Testing Support Keeps Fair Value In Focus
Roche Holding (SWX:ROP) has been back in focus after Roche Diagnostics shipped two molecular testing instruments to support Ebola response efforts in the Democratic Republic of Congo, tying humanitarian work directly to the diagnostics segment. Against this backdrop, Roche Holding shares trade at CHF352.7 after a 1-day share price return that declined 2.03%. The 90-day share price return of 4.78% and 1-year total shareholder return of 23.81% indicate that momentum has been gradually building...
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo